Your browser doesn't support javascript.
loading
Neoadjuvant therapy versus upfront surgery for borderline-resectable pancreatic cancer.
Han, Sunjong; Choi, Seong H; Choi, Dong W; Heo, Jin S; Han, In W; Park, Dae-Joon; Ryu, Youngju.
Affiliation
  • Han S; Departments of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Sungnam, South Korea.
  • Choi SH; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea - sh3468.choi@samsung.com.
  • Choi DW; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Heo JS; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Han IW; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Park DJ; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Ryu Y; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Minerva Chir ; 75(1): 15-24, 2020 Feb.
Article in En | MEDLINE | ID: mdl-31115240
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Neoadjuvant Therapy Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Minerva Chir Year: 2020 Type: Article Affiliation country: South Korea
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Neoadjuvant Therapy Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Minerva Chir Year: 2020 Type: Article Affiliation country: South Korea